PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
- Status
- TERMINATED
- Phase
- PHASE2
Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
- Status
- UNKNOWN
- Phase
- N/A
A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1
Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Allo HSCT Using RIC for Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
- Status
- COMPLETED
- Phase
- PHASE1
Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)
- Status
- WITHDRAWN
- Phase
- PHASE3
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
- Status
- COMPLETED
- Phase
- N/A
Dose Optimization Study of Idelalisib in Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1
- Status
- COMPLETED
- Phase
- N/A
Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2